medication
DomesticBiological Product
Recombinant Insulin Glargine
甘李药业股份有限公司
Drug Information
| Generic name | 重组甘精胰岛素 |
|---|---|
| English name | Recombinant Insulin Glargine |
| Dosage form | Active ingredient (API) |
| Specification | ---- |
| Category | Biological Product |
| Approval no. | 国药准字S20130005 |
| Drug code | 86900227000084 |
| Manufacturer | 甘李药业股份有限公司 |
| Production address | 北京市通州区漷县镇南凤西一路8号 |
| Origin | Domestic |
| Approval date | 2018-03-07 |
Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.